DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Bought by Epoch Investment Partners Inc.

Epoch Investment Partners Inc. raised its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 2.2% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 30,169 shares of the medical instruments supplier’s stock after purchasing an additional 647 shares during the period. Epoch Investment Partners Inc.’s holdings in DENTSPLY SIRONA were worth $752,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Prospector Partners LLC increased its position in DENTSPLY SIRONA by 76.7% during the 2nd quarter. Prospector Partners LLC now owns 674,970 shares of the medical instruments supplier’s stock valued at $16,814,000 after buying an additional 293,030 shares in the last quarter. Summit Trail Advisors LLC purchased a new stake in DENTSPLY SIRONA during the 2nd quarter worth approximately $256,000. Thrivent Financial for Lutherans grew its position in DENTSPLY SIRONA by 8.5% during the 2nd quarter. Thrivent Financial for Lutherans now owns 353,194 shares of the medical instruments supplier’s stock worth $8,798,000 after purchasing an additional 27,708 shares during the last quarter. Sei Investments Co. increased its stake in DENTSPLY SIRONA by 32.2% during the 2nd quarter. Sei Investments Co. now owns 572,537 shares of the medical instruments supplier’s stock valued at $14,262,000 after purchasing an additional 139,578 shares in the last quarter. Finally, Pacer Advisors Inc. raised its holdings in shares of DENTSPLY SIRONA by 116.6% in the second quarter. Pacer Advisors Inc. now owns 31,160 shares of the medical instruments supplier’s stock worth $776,000 after buying an additional 16,776 shares during the last quarter. Hedge funds and other institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Stock Performance

Shares of NASDAQ XRAY opened at $26.17 on Tuesday. The company has a market capitalization of $5.43 billion, a PE ratio of -59.48, a price-to-earnings-growth ratio of 1.25 and a beta of 1.00. The company has a debt-to-equity ratio of 0.57, a quick ratio of 0.87 and a current ratio of 1.33. The company’s fifty day moving average price is $25.57 and its 200 day moving average price is $27.77. DENTSPLY SIRONA Inc. has a 1 year low of $23.58 and a 1 year high of $37.60.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its earnings results on Wednesday, July 31st. The medical instruments supplier reported $0.49 EPS for the quarter, missing analysts’ consensus estimates of $0.50 by ($0.01). The business had revenue of $984.00 million for the quarter, compared to analyst estimates of $993.61 million. DENTSPLY SIRONA had a negative net margin of 4.75% and a positive return on equity of 11.86%. DENTSPLY SIRONA’s revenue was down 4.3% on a year-over-year basis. During the same quarter last year, the business earned $0.51 earnings per share. On average, research analysts predict that DENTSPLY SIRONA Inc. will post 1.99 earnings per share for the current year.

DENTSPLY SIRONA Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 11th. Investors of record on Friday, September 27th will be paid a $0.16 dividend. The ex-dividend date is Friday, September 27th. This represents a $0.64 dividend on an annualized basis and a yield of 2.45%. DENTSPLY SIRONA’s dividend payout ratio is currently -145.45%.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on the company. Robert W. Baird reduced their target price on DENTSPLY SIRONA from $33.00 to $31.00 and set a “neutral” rating for the company in a research note on Monday, July 22nd. Stifel Nicolaus reduced their price objective on DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating for the company in a research note on Thursday, July 18th. Evercore ISI dropped their target price on DENTSPLY SIRONA from $28.00 to $27.00 and set an “outperform” rating on the stock in a research report on Tuesday, July 9th. Needham & Company LLC reissued a “buy” rating and set a $34.00 price target on shares of DENTSPLY SIRONA in a research report on Tuesday, August 20th. Finally, Barrington Research reaffirmed an “outperform” rating and issued a $36.00 price objective on shares of DENTSPLY SIRONA in a report on Friday. Five investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $33.22.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.